Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships

Chemico-Biological Interactions

Volumn 174, Issue 1, 2008, Pages 51-59

  Meng, Xue Lian ^a   Yang, Jing Yu ^a   Chen, Guo Liang ^a   Wang, Li Hui ^a   Zhang, Li Jia ^a   Wang, Shu ^a   Li, Jie ^a   Wu, Chun Fu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

I B ; iNOS; Microglia; Nitric oxide; Resveratrol; Structure activity relationships; TNF

Indexed keywords

I KAPPA B ALPHA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RESVERATROL;

ANIMAL CELL; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MICROGLIA; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITROPRUSSIDE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SOLUTIONS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45849091854     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.04.015     Document Type: Article

References (35)

1. Gonzalez-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22 (1999) 219-240
2. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
3. Stoll G., and Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58 (1999) 233-247
4. Nakajima K., and Kohsaka S. Microglia: activation and their significance in the central nervous system. J. Biochem. 130 (2001) 169-175
5. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., and Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7 (1993) 75-83
6. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., and McGeer E.G. Microglia in degenerative neurological disease. Glia 7 (1993) 84-92
7. Boyle E.A., and McGeer P.L. Cellular immune response in multiple sclerosis plaques. Am. J. Pathol. 137 (1990) 575-584
8. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
9. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
10. Bradamante S., Barenghi L., and Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 22 (2004) 169-188
11. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126 (1999) 673-680
12. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., and Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175 (2005) 3339-3346
13. Wang Q., Xu J., Rottinghaus G.E., Simonyi A., Lubahn D., Sun G.Y., and Sun A.Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958 (2002) 439-447
14. Okawara M., Katsuki H., Kurimoto E., Shibata H., Kume T., and Akaike A. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem. Pharmacol. 73 (2007) 550-560
15. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., and Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem. 280 (2005) 40364-40374
16. Anekonda T.S. Resveratrol-a boon for treating Alzheimer's disease?. Brain Res. Rev. 52 (2006) 316-326
17. Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., and Neri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37 (2005) 349-350
18. Bi X.L., Yang J.Y., Dong Y.X., Wang J.M., Cui Y.H., Ikeshima T., Zhao Y.Q., and Wu C.F. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int. J. Immunopharmacol. 5 (2005) 185-193
19. Chen G., Shan W., Wu Y., Ren L., Dong J., and Ji Z. Synthesis and anti-inflammatory activity of resveratrol analogs. Chem. Pharm. Bull. 53 (2005) 1587-1590
20. Hougee S., Faber J., Sanders A., de Jong R.B., van den Berg W.B., Garssen J., Hoijer M.A., and Smit H.F. Selective COX-2 inhibition by a Pterocarpus marsupium extract characterized by pterostilbene, and its activity in healthy human volunteers. Planta Med. 71 (2005) 387-392
21. Matsuda H., Kageura T., Morikawa T., Toguchida L., Harima S., and Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg. Med. Chem. Lett. 10 (2000) 323-327
22. Cho D.I., Koo N.Y., Chung W.J., Kim T.S., Ryu S.Y., Im S.Y., and Kim K.M. Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci. 71 (2002) 2071-2082
23. Goldberg D.M., Ng E., Karumanchiri A., Yan J., Diamandis E.P., and Soleas G.J. Assay of resveratrol glucosides and isomers in wine by direct-injection high-performance liquid chromatography. J. Chromatogr. A 708 (1995) 984-989
24. Jeandet P., Bessis R., Maume B.F., Meunier P., Peyron D., and Trollat P. Effect of enological practices on the resveratrol isomer content of wine. J. Agric. Food Chem. 43 (1995) 316-319
25. Trela B.C., and Waterhouse A.L. Resveratrol: isomeric molar absorptivities and stability. J. Agric. Food Chem. 44 (1996) 1253-1257
26. Barger S.W., and Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388 (1997) 878-881
27. Chang J.Y., Chavis J.A., Liu L.Z., and Drew P.D. Cholesterol oxides induce programmed cell death in microglial cells. Biochem. Biophys. Res. Commun. 249 (1998) 817-821
28. Marcocci L., Maguire J.J., Droy-Lefaix M.T., and Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun. 201 (1994) 748-755
29. Tzeng S.F., and Huang H.Y. Downregulation of inducible nitric oxide synthetase by neurotrophin-3 in microglia. J. Cell Biochem. 90 (2003) 227-233
30. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., and Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60 (2000) 1539-1548
31. 24. Nitric Oxide 11 (2004) 201-207
32. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
33. Moynagh P.N. The NF-kappaB pathway. J. Cell Sci. 118 (2005) 4589-4592
34. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20
35. Henkel T., Zabel U., van Zee K., Müller J.M., Fanning E., and Baeuerle P.A. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68 (1992) 1121-1133